Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 7, 2012OncotargetOpen Access

Glyceraldehyde-3-Phosphate Dehydrogenase: A Promising Target for Molecular Therapy in Hepatocellular Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

SGShanmugasundaram Ganapathy‐KanniappanUniversity of Maryland, BaltimoreRKRani KunjithapathamJohns Hopkins UniversityJGJean-François H. GeschwindYale New Haven Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ganapathy‐Kanniappan et al. (2012) studied this question.

synapsesocial.com/papers/69dcc7171e43378fbd13338ehttps://doi.org/10.18632/oncotarget.623
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma2011 · 44 citations
  2. 2Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interaction with 3' ends of Japanese encephalitis virus RNA and colocalization with the viral NS5 protein2009 · 51 citations
  3. 3Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate12008 · 172 citations